Skip to content
Clinical Trials – home

Doxycycline Hyclate: A Versatile Antibiotic for Various Conditions

2 / 3
trials open to patients / all trials
8+
Countries

In short

Doxycycline Hyclate, a versatile antibiotic, is being studied in several clinical trials for its effectiveness in treating various medical conditions. This article explores the ongoing research on Doxycycline Hyclate, highlighting its potential applications in acne, sexually transmitted infections, thyroid-associated ophthalmopathy, and other disorders. We'll examine the different dosages, administration methods, and comparative studies to provide a comprehensive overview of this drug's role in current medical research.

What is Doxycycline Hyclate?

Doxycycline Hyclate is an antibiotic medication that belongs to the tetracycline class of drugs. It is widely used to treat various bacterial infections and has anti-inflammatory properties. Doxycycline Hyclate is known by several other names, including Doryx, Vibramycin, Doxine, and simply doxycycline.

Uses of Doxycycline Hyclate

Doxycycline Hyclate is prescribed for a variety of conditions due to its effectiveness against different types of bacteria. Some of the main uses include:

  • Acne vulgaris: A common skin condition characterized by pimples, blackheads, and whiteheads
  • Sexually transmitted infections (STIs): Particularly chlamydia and sometimes used for prevention
  • Respiratory tract infections: Such as pneumonia or bronchitis
  • Periodontal disease: Infections of the gums and supporting structures of the teeth
  • Certain eye conditions: Including some types of inflammation

Doxycycline for Acne Treatment

Doxycycline Hyclate is commonly used to treat moderate to severe acne vulgaris. Clinical trials have shown its effectiveness in reducing inflammatory acne lesions (red, swollen pimples) and improving overall skin appearance.

In one study, researchers compared the effectiveness of different dosages of doxycycline for acne treatment. They found that a lower dose of 20 mg twice daily (known as a sub-antimicrobial dose) could be as effective as the standard 100 mg twice daily dose, potentially reducing the risk of antibiotic resistance.

Another study compared the effectiveness of doxycycline to spironolactone, a hormone-based treatment, for acne in women. This research aims to find alternatives to long-term antibiotic use for acne treatment.

Doxycycline for STI Prevention

Recent research has explored the use of doxycycline for preventing sexually transmitted infections (STIs), particularly in high-risk populations. A clinical trial called DISCO (Doxycycline Intervention for STI ChemoprophOlaxis) is investigating whether taking doxycycline can help prevent bacterial STIs such as chlamydia, gonorrhea, and syphilis in men who have sex with men (MSM).

The study compares two approaches:

  1. STI PrEP (Pre-Exposure Prophylaxis): Taking 100 mg of doxycycline daily
  2. STI PEP (Post-Exposure Prophylaxis): Taking 200 mg of doxycycline within 24-72 hours after a sexual encounter deemed risky

This research could potentially provide a new tool for STI prevention in high-risk populations.

Other Conditions Treated with Doxycycline

Doxycycline Hyclate has shown promise in treating various other conditions:

  • Thyroid-Associated Ophthalmopathy: A condition affecting the eyes in some people with thyroid disorders. A study is investigating whether doxycycline can help reduce inflammation and swelling in the eyes.
  • Heart Protection After Heart Attacks: Researchers are studying whether doxycycline can help protect heart muscle after a heart attack by inhibiting certain proteins that can cause damage during recovery.
  • Oral Mucositis in Cancer Patients: A study is looking at whether low doses of doxycycline can prevent or reduce mouth sores (oral mucositis) in patients undergoing chemotherapy for leukemia.

Dosage and Administration

The dosage of Doxycycline Hyclate varies depending on the condition being treated:

  • For acne: Doses can range from 20 mg to 100 mg twice daily, depending on the severity and the doctor's recommendation.
  • For STI treatment: Typically 100 mg twice daily for 7 days.
  • For STI prevention (in clinical trials): 100 mg daily or 200 mg after potential exposure.

Doxycycline is usually taken orally in the form of tablets or capsules. It's important to follow your doctor's instructions carefully and complete the full course of treatment, even if you start feeling better before it's finished.

Side Effects and Safety

Like all medications, Doxycycline Hyclate can cause side effects. Common side effects may include:

  • Nausea or vomiting
  • Diarrhea
  • Skin sensitivity to sunlight
  • Headache

More serious side effects are rare but can occur. It's important to discuss potential risks and side effects with your healthcare provider before starting treatment.

Doxycycline should not be used in children under 8 years old or in pregnant women, as it can affect bone and tooth development in growing children and fetuses.

Questions people often ask

Conditions where Doxycycline Hyclate is being studied

Each condition opens its own overview and trial list

Trials with Doxycycline Hyclate

Recruiting trials first

See all 3 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).